Qizheng Tibetan Medicine (002287.SZ): Net profit of 97.468 million yuan in the first quarter increased 5.06% year-on-year

Gelonghui, April 26 | Qizheng Tibetan Pharmaceutical (002287.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 365 million yuan, up 23.37% year on year; net profit attributable to shareholders of listed companies was 97.468 million yuan, up 5.06% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 56.0285 million yuan, an increase of 77.42% year on year; basic earnings per share were 0.1,838 yuan.

Gelonghui FinanceApr 26 07:48 ET

Qizheng Tibetan Medicine (002287.SZ): 2023 net profit of 581 million yuan, plans to distribute 10 to 4.8 yuan

Gelonghui, April 18 | Qizheng Tibetan Medicine (002287.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 2,045 billion yuan, up 0.02% year on year; net profit attributable to shareholders of listed companies was 581 million yuan, up 22.99% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 370 million yuan, down 15.94% year on year; basic income per share was 1.0972 yuan; plans to distribute a cash dividend of 4.8 yuan (tax included) to all shareholders for every 10 shares.

Gelonghui FinanceApr 18 04:33 ET

Qizheng Tibetan Medicine (002287.SZ): As of March 29, 2024, the total number of shareholders of the company was 20,787

Gelonghui, April 1 | Qizheng Tibetan Medicine (002287.SZ) said on an interactive platform that as of March 29, 2024, the total number of shareholders of the company was 20,787.

Gelonghui FinanceApr 1 03:10 ET

Qizheng Tibetan Medicine (002287.SZ): As of March 20, 2024, the total number of shareholders of the company was 2,113

Gelonghui March 21丨Qizheng Tibetan Medicine (002287.SZ) said on an interactive platform that as of March 20, 2024, the total number of shareholders of the company was 21,113.

Gelonghui FinanceMar 21 03:09 ET

Tianyou German Liquor (002646.SZ): There is no cooperation with Qizheng Tibetan Medicine related to barley wine

Gelonghui March 19 丨 Some investors asked Tianyou Liquor (002646.SZ) on the investor interactive platform, “Do Tianyou Dejiu and Qizheng Tibetan Medicine cooperate on barley wine?” The company replied that there is no cooperation between the company and Qizheng Tibetan Medicine (002287) related to barley wine.

Gelonghui FinanceMar 19 04:52 ET

Qizheng Tibetan Medicine (002287.SZ): “Baitai Biologics New Drug Clinical Research Ethane Selenium Project” has been terminated

Gelonghui March 19 丨 Some investors asked Qizheng Tibetan Medicine (002287.SZ) on the investor interactive platform, “In which countries are listed companies' complete vehicles and accessories sold?” The company replied that the company's “Baitai Biotech New Drug Clinical Research Ethane Selenium Project” has been terminated. Anti-cancer drug development has the characteristics of high capital requirements, long cycle time, and relatively high risk. Please pay attention to investment risks.

Gelonghui FinanceMar 19 03:35 ET